Health
GSK’s ARV vaccine shows potential in adults aged 50-59 years
GSK said its respiratory syncytial virus vaccine showed positive preliminary results in a late-stage study to protect adults aged 50 to 59 from the disease,
US states sue Instagram over depression, anxiety and insomnia in children
Dozens of US states have sued Meta Platforms and its Instagram unit, accusing them of fuelling a youth mental health crisis by making their social
Georgia Supreme Court upholds six-week abortion ban
A Georgia law banning most abortions after six weeks of pregnancy can remain in effect, the state’s highest court ruled Tuesday, rejecting a challenge from
Belgium plans temporary ban on the use of Ozempic for weight loss
Belgium wants to temporarily ban the use of Novo Nordisk’s diabetes drug Ozempic as a weight-loss treatment amid a shortage of the drug, Belgium’s health
The US FDA has accepted AstraZeneca’s standalone flu vaccine for review
AstraZeneca said the U.S. Food and Drug Administration has accepted the company’s application for approval for patients or caregivers to administer its nasal influenza vaccine.
The US FDA has accepted AstraZeneca’s standalone flu vaccine for review
AstraZeneca said Tuesday that the U.S. Food and Drug Administration (FDA) has accepted for review the company’s application for approval for patients or caregivers to
EU establishes new mechanisms to prevent shortages of medicines
The European Commission on Tuesday launched a series of short-term measures to prevent shortages of medicines this winter and next as a temporary solution while
Suspected counterfeit Ozempic forces hospitalisation of several people in Austria
Several people were hospitalised in Austria after consuming suspected counterfeit versions of the diabetes drug Ozempic, the country’s health safety agency said. The patients suffered
Pfizer will set the price for COVID-19 treatment with Paxlovid at $1390 per course
Pfizer on Wednesday said it would set the U.S. price for its COVID-19 antiviral drug Paxlovid at nearly $1400 for a five-day course when the
Nestle begins work on ‘companion products’ for weight loss medication
Nestle on Thursday said it has started work on products that will “complement” weight-loss drugs such as Novo Nordisk’s revolutionary Wegovy, hoping to capitalise on